Search Videos by Topic or Participant
Browse by Series:

Emerging Therapies in Prostate Cancer

Panelists: Raoul S. Concepcion, MD, Urology Associates, PC; Steve Dobbs, Urologic Associates of Oklahoma; Bryan A. Mehlhaff, MD, Oregon Urology Institute;
Published: Wednesday, Jan 16, 2013
For High-Definition, Click
Raoul D. Concepcion, MD, introduces the topic of emerging therapies in patients with castration-resistant prostate cancer. Currently, in the docetaxel failure state, cabazitaxel, abiraterone, and enzalutamide are approved.

Concepcion highlights several key agents in phase III clinical trials. Alpharadin or radium-223 is an alpha radiopharmaceutical that has a narrow depth of penetration but has a survival benefit alone as well as response for pain relief and reduction of skeletal-related events.

Concepcion also mentions Oteronel or TAK-700, an oral agent, and Aragon or 509, an androgen signaling inhibitor.
Slider Left
Slider Right
For High-Definition, Click
Raoul D. Concepcion, MD, introduces the topic of emerging therapies in patients with castration-resistant prostate cancer. Currently, in the docetaxel failure state, cabazitaxel, abiraterone, and enzalutamide are approved.

Concepcion highlights several key agents in phase III clinical trials. Alpharadin or radium-223 is an alpha radiopharmaceutical that has a narrow depth of penetration but has a survival benefit alone as well as response for pain relief and reduction of skeletal-related events.

Concepcion also mentions Oteronel or TAK-700, an oral agent, and Aragon or 509, an androgen signaling inhibitor.
View Conference Coverage
Online CME Activities
TitleExpiration DateCME Credits
Community Practice Connections™: Personalized Sequencing in Castration-Resistant Prostate Cancer: Bridging the Latest Evidence to the Bedside in Clinical ManagementAug 25, 20181.5
Community Practice Connections™: Precision Medicine for Community Oncologists: Assessing the Role of Tumor-Testing Technologies in Cancer CareNov 30, 20181.0
Publication Bottom Border
Border Publication
x